RoscoPharm ApS — Credit Rating and Financial Key Figures
CVR number: 43431102
Gentoftegade 56 B, 2820 Gentofte
pr@rosco.dk
tel: 31542394
Income statement (kDKK)
2023 | 2024 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 30.34 | |
| Other operating expenses | -40.00 | -42.84 |
| EBIT | -40.00 | -12.50 |
| Other financial income | 0.54 | |
| Other financial expenses | -0.65 | |
| Pre-tax profit | -40.00 | -12.61 |
| Net earnings | -40.00 | -12.61 |
Assets (kDKK)
| Intangible assets total |
| Tangible assets total |
| Investments total |
| Long term receivables total |
| Inventories total |
| Short term receivables total |
| Balance sheet total (assets) |
Equity and liabilities (kDKK)
2023 | 2024 | |
|---|---|---|
| Share capital | 40.00 | 40.00 |
| Other reserves | 12.61 | |
| Retained earnings | -40.00 | |
| Profit of the financial year | -40.00 | -12.61 |
| Shareholders equity total | ||
| Non-current liabilities total | ||
| Current liabilities total | ||
| Balance sheet total (liabilities) |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.